TNFSF10 and neoplasm: Collectively, these results indicate that the TRAIL protein secreted from bioprinted NHF1TRAIL is functionally active at therapeutic concentrations for TRAIL-sensitive tumor cells, but the reduction in TRAIL secretion due to protein entrapment by the material may result in insufficient tumor killing, especially if the tumor is TRAIL-resistant.